Alnylam Pharmaceuticals (ALNY) Change in Taxes (2009 - 2010)
Alnylam Pharmaceuticals (ALNY) posted Change in Taxes of $30000.0 for Q4 2010, up 2900.0% on a QoQ basis from $1000.0 in Q3 2010, and down 99.31% year-over-year from $4.3 million in Q4 2009.
Alnylam Pharmaceuticals (ALNY) Change in Taxes (2009 - 2010) Analysis & Trends
Alnylam Pharmaceuticals' Change in Taxes history runs 2 years deep, the most recent figure standing at $30000.0 for Q4 2010.
- Quarterly Change in Taxes fell 99.31% year-over-year to $30000.0 in Q4 2010, while the trailing twelve-month figure through Dec 2010 was -$5.5 million (changed N/A YoY) and the FY2010 annual result came in at -$5.5 million, down 1081.16% from the prior year.
- Change in Taxes was $30000.0 for Q4 2010 at Alnylam Pharmaceuticals, up from $1000.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $4.3 million in Q4 2009 and bottomed at -$5.5 million in Q1 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 30,000.00 |
| Dec 31, 2010 | 30,000.00 |
| Sep 30, 2010 | 1,000.00 |
| Sep 30, 2010 | 1,000.00 |
| Jun 30, 2010 | -1,000.00 |
| Jun 30, 2010 | -1,000.00 |
| Mar 31, 2010 | -5.55 Mn |
| Mar 31, 2010 | -5.55 Mn |
| Dec 31, 2009 | 4.33 Mn |
| Dec 31, 2009 | 4.33 Mn |
| Sep 30, 2009 | -512,000.00 |
| Sep 30, 2009 | -512,000.00 |